Clinical Perspectives

Revolutionizing Thyroid Surgeries with Autofluorescence Technology

A groundbreaking innovation leading the charge in improving surgical outcomes for thyroid and parathyroid surgeries is autofluorescence technology.

Transforming Treatment for Refractory Metastatic Melanoma: FDA Approval of TIL

The recent FDA approval of Lifileucel TIL therapy presents a groundbreaking advancement in the realm of solid tumor cancer treatment.

Moffitt's CARDIO-CATCH Clinic for Clonal Hematopoiesis

With a strong commitment to understanding and addressing the implications of clonal hematopoiesis mutations, Moffitt is pioneering a groundbreaking...

Leaders in the Use of Navigated Bone Tumor Resections and Custom Implant Reconstruction

Increasing research demonstrates that navigated resections, especially in complicated locations like the pelvis, can improve cancer-specific...

Advancements in Robotic Surgery for Radical Stump Trachelectomy

A radical stump trachelectomy is the removal of the cervix and not the uterus using a minimally invasive surgery technique.

Imetelstat Shows Promising Results for Lower-Risk MDS in a Phase 2 Trial

Dr. Rami Komrokji, Vice Chair of the Malignant Hematology Program, is a joint senior author on a high-impact paper recently published in The Lancet.

Benefits of Prostatic Artery Embolization in Prostate Cancer Treatment

Dr. Nainesh Parikh, assistant chief Medical officer and interventional radiologist, joined the BackTable Podcast to discuss patient outcomes...

Dr. Jose Pimiento Appointed American College of Surgeons Commission on Cancer State Chair

Dr. Jose Pimiento was appointed state chair of the American College of Surgeons Commission on Cancer (CoC) Cancer Liaison Program.

Dr. Arnold Etame Receives NIH R01 Award for Novel Research

Dr. Arnold Etame has received an NIH R01 Award for his novel research "Targeting Malignant Reprogramming of Glioblastoma Stem Cells Through Dual...

Dr. Kim Presents Research Findings Investigating the Use of Regorafenib in mCRC

Richard Kim, MD, a senior member of the Gastrointestinal Oncology Program, recently presented at the 2024 Gastrointestinal Cancer Symposium.

Head and Neck-Endocrine Program’s Multidisciplinary Model Offers Patients Enhanced Treatment

The Head and Neck-Endocrine Oncology Program offers a multidisciplinary model that involves specialists from various fields seeing a patient...

Artificial Intelligence is Helping Deliver Cancer Outcomes Better than the National Average

Nowhere are we exploring AI, and its subcategory machine learning (ML), with more important consequences than the field of oncology.

Why We Built the First Machine Learning Department in Oncology

The resurgence of AI and its machine learning algorithms has created tremendous excitement for AI/ML prospects in cancer research.

The Future of Ovarian Cancer Treatment with Antibody-Drug Conjugates (ADCs)

The relentless pursuit of improving treatment for ovarian cancer has led to better outcomes and created new standards of care for ovarian cancer.

Chimeric RNAs Reveal Putative Neoantigen Peptides for Developing Tumor Vaccines for Breast Cancer

Dr. Brian Czerniecki, chair of the Breast Oncology Program, co-authored the publication, “Chimeric RNAs reveal putative neoantigen peptides for...